Form SC 13G - Statement of acquisition of beneficial ownership by individuals

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

null

Enveric Biosciences (NASDAQ:ENVB)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024

Plus de graphiques de la Bourse Enveric Biosciences

Enveric Biosciences (NASDAQ:ENVB)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024

Plus de graphiques de la Bourse Enveric Biosciences

Actualités Enveric Biosciences Inc

Enveric Biosciences Provides Strategic Outlook and Pipeline Update, Elevating EB-003 to Lead Development Candidate
Mardi 25 Juin 2024 ( il y a 5 jours) • Business Wire

Form 3 - Initial statement of beneficial ownership of securities
Mardi 4 Juin 2024 ( il y a 4 semaines) • Edgar (US Regulatory)

Enveric Biosciences to Participate in BIO International Convention 2024
Jeudi 30 Mai 2024 ( il y a 1 mois) • Business Wire

Form 8-K - Current report
Mercredi 29 Mai 2024 ( il y a 1 mois) • Edgar (US Regulatory)

Form 8-K - Current report
Jeudi 23 Mai 2024 ( il y a 1 mois) • Edgar (US Regulatory)

Form 8-K - Current report
Vendredi 17 Mai 2024 ( il y a 1 mois) • Edgar (US Regulatory)

Enveric Biosciences Reports First Quarter 2024 Financial and Corporate Results
Mercredi 15 Mai 2024 ( il y a 2 mois) • Business Wire

Enveric Biosciences Signs $66.5 Million Non-Binding Term Sheet with MindBio Therapeutics to Out-License Novel Psilocin Prodrug Candidate for Mental Health Disorders
Mardi 14 Mai 2024 ( il y a 2 mois) • Business Wire

Enveric Biosciences Announces Signing of Non-Binding Term Sheet with Undisclosed Licensee for Exclusive License to Patented Methods of Treating Breast and Other Cancers Using Cannabinoids
Mercredi 8 Mai 2024 ( il y a 2 mois) • Business Wire

Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2023
Mardi 26 Mars 2024 ( il y a 3 mois) • Business Wire

Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of New Chemical Entities for Pharmaceutical and Non-Pharmaceutical Applications in Joint Disease
Mardi 19 Mars 2024 ( il y a 3 mois) • Business Wire

Enveric Biosciences Announces New Patent Issuances Protecting Multiple Assets Covered by Non-Binding Term Sheets
Mardi 12 Mars 2024 ( il y a 4 mois) • Business Wire

Plus d'articles sur Enveric Biosciences Inc

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales